EPRX   $3.49  -1.97% Market Closed

Eupraxia Pharmaceuticals Inc
Total Cash 23.32M
totalCashPerShare 0.655
EBITDA -31.76M
Total Debt 4.66M
quickRatio 2.023
currentRatio 2.114
Total Revenue
debtToEquity 34.939
Revenue/Share
ROA -0.98680997
ROE -3.14408
grossProfits
freeCashflow -14.62M
operatingCashflow -25.68M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 90.28M
forwardPE
floatShares 30.17M
sharesOutstanding 35.62M
sharesShort 128.16K
sharesShortPriorMonth 128.44K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.13%
Short Ratio help_outline 27.74%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.416
Price To Book help_outline 7.45
earningsQuarterlyGrowth
netIncomeToCommon -27.00M
trailingEps -0.93%
forwardEps
enterpriseToEbitda -2.84
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 11
lastUpdated Nov. 2, 2024, 7:18 a.m.